ArticleJournal of managed care & specialty pharmacy2018

Intravitreal Aflibercept Versus Ranibizumab for Wet Age-Related Macular Degeneration: A Cost-Effectiveness Analysis.

Luis Hernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.